Resources & Articles

PicnicHealth is excited to announce our Holiday 2021 Donation Campaign. PicnicHealth is donating to patient advocacy groups everytime a patient joins a PicnicHealth research study until January 2, 2022.

We’re beginning a series: “Good Data Is”, where we’ll take a look at how to build good data and explore how best to optimize data capture, transformation and patient engagement

The American Society of Hematology (ASH) recently accepted two of our abstracts for the upcoming 63rd ASH Annual Meeting, which will be held December 11-14, 2021.

he Evidence Base and PicnicHealth partnered to put Data Completeness In Focus. Dan Drozd, MD, PicnicHealth’s Chief Medical Officer sat down with Darcy Hodge, Editor of the Evidence Base to talk about the importance of data completeness, unstructured data and additional factors that impact the generation of high-quality real-world evidence. Listen to the podcast, part of the In Focus feature by visiting The Evidence Base. A transcript of the interview appears below.

Sickle cell disease is the most common inherited blood disorder in the United States. The Centers for Disease Control and Prevention estimate that 100,000 people are living with sickle cell in the US

Recognizing the need for accelerating medical product development and modernizing the drug approval process, the 21st Century CURES Act was enacted in 2016 and augmented the ability for the FDA to incorporate real world data and patient perspectives into the drug approval process. While randomized clinical trials are still the gold standard, observational data is increasingly utilized to supplement clinical trial design, as synthetic controls in single arm trials and for label expansion.

PicnicHealth partners with life science companies, academic research institutions, and health systems organizations in applying real world evidence for the advancement of patient care and treatment. We produce high quality multimodel datasets that cover a patient’s entire medical journey and are more comprehensive and customizable than existing sources of real-world data.